NCT07402876Phase 3Recruiting

A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma

Study sponsor: Aldeyra Therapeutics, Inc. · ALDX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-12Estimated
Enrollment · participants20Estimated
Source updated2026-11-16Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Dec 2026. After: Dec 2029.

Check registry source